Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Schuster

Showing results (311-320 of 353) with videos related to

Pageof 36
Sort By:
JAMA Network Open|February 7, 2023
Circulation of Rhinoviruses and/or Enteroviruses in Pediatric Patients With Acute Respiratory Illness Before and During the COVID-19 Pandemic in the USDanielle A Rankin, Andrew J Spieker, Ariana Perez, et al.
The Pediatric Infectious Disease Journal|September 14, 2022
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 InfectionLaura D Zambrano, Kathleen N Ly, Ruth Link-Gelles, et al.
Open Forum Infectious Diseases|November 28, 2025
Adenovirus Types in US Children Hospitalized or Seen in the Emergency Department With Acute Respiratory Illness, 2016-2019Tess Stopczynski, Varvara Probst, Adam Gailani, et al.
MMWR. Morbidity and Mortality Weekly Report|March 8, 2024
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024Heidi L Moline, Ayzsa Tannis, Ariana P Toepfer, et al.
The Pediatric Infectious Disease Journal|December 27, 2021
Frequency, Characteristics and Complications of COVID-19 in Hospitalized InfantsCharlotte V Hobbs, Kate Woodworth, Cameron C Young, et al.
MMWR. Morbidity and Mortality Weekly Report|October 21, 2021
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021Samantha M Olson, Margaret M Newhams, Natasha B Halasa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2023
Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in ChildrenJoyce C Chang, Cameron C Young, Eyal Muscal, et al.
Epidemiology (Cambridge, Mass.)|May 18, 2022
Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic MisclassificationAvnika B Amin, Timothy L Lash, Jacqueline E Tate, et al.
MMWR. Morbidity and Mortality Weekly Report|January 13, 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021Laura D Zambrano, Margaret M Newhams, Samantha M Olson, et al.
Pediatrics|June 18, 2020
Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016Brian Rha, Aaron T Curns, Joana Y Lively, et al.
Pageof 36

Showing results (311-320 of 353) with videos related to

Sort By:
Pageof 36
JAMA Network Open|February 7, 2023
Circulation of Rhinoviruses and/or Enteroviruses in Pediatric Patients With Acute Respiratory Illness Before and During the COVID-19 Pandemic in the USDanielle A Rankin, Andrew J Spieker, Ariana Perez, et al.
The Pediatric Infectious Disease Journal|September 14, 2022
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 InfectionLaura D Zambrano, Kathleen N Ly, Ruth Link-Gelles, et al.
Open Forum Infectious Diseases|November 28, 2025
Adenovirus Types in US Children Hospitalized or Seen in the Emergency Department With Acute Respiratory Illness, 2016-2019Tess Stopczynski, Varvara Probst, Adam Gailani, et al.
MMWR. Morbidity and Mortality Weekly Report|March 8, 2024
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024Heidi L Moline, Ayzsa Tannis, Ariana P Toepfer, et al.
The Pediatric Infectious Disease Journal|December 27, 2021
Frequency, Characteristics and Complications of COVID-19 in Hospitalized InfantsCharlotte V Hobbs, Kate Woodworth, Cameron C Young, et al.
MMWR. Morbidity and Mortality Weekly Report|October 21, 2021
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021Samantha M Olson, Margaret M Newhams, Natasha B Halasa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2023
Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in ChildrenJoyce C Chang, Cameron C Young, Eyal Muscal, et al.
Epidemiology (Cambridge, Mass.)|May 18, 2022
Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic MisclassificationAvnika B Amin, Timothy L Lash, Jacqueline E Tate, et al.
MMWR. Morbidity and Mortality Weekly Report|January 13, 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021Laura D Zambrano, Margaret M Newhams, Samantha M Olson, et al.
Pediatrics|June 18, 2020
Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016Brian Rha, Aaron T Curns, Joana Y Lively, et al.
Pageof 36